1. Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma;AbuHammad;Proc. Natl. Acad. Sci. U S A,2019
2. Cdc2-cyclin E complexes regulate the G1/S phase transition;Aleem;Nat. Cell Biol.,2005
3. A systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells;Anders;Cancer Cell,2011
4. The history and future of targeting cyclin-dependent kinases in cancer therapy;Asghar;Nat. Rev. Drug Discov.,2015
5. Behenna, D.C., Chen, P., Freeman-Cook, K.D., Hoffman, R.L., Jalaie, M., Nagata, A., Nair, S.K., Ninkovic, S., Ornelas, M.A., Palmer, C.L., and Rui, E.Y. (2018). CDK2/4/6 inhibitors. USA Patent Application Publication US 2018/0044344 A1.